Thrombogenicity testing of central venous catheters in vitro

Infection

Volumn 27, Issue SUPPL. 1, 1999, Pages

  Boswald M ^a   Lugauer, S ^a   Bechert, T ^a   Greil, J ^a   Regenfus, Anja ^a   Guggenbichler, J P ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; CITRATE SODIUM; HEMOGLOBIN; POLYETHYLENE; PROTHROMBIN; THROMBIN;

ANTICOAGULATION; ARTICLE; BLOOD FLOW; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; ERYTHROCYTE COUNT; HEMOLYSIS; HUMAN; IN VITRO STUDY; THROMBOCYTE COUNT; THROMBOGENICITY;

ANTITHROMBIN III; CATHETERIZATION, CENTRAL VENOUS; HEMOGLOBINS; HUMANS; MATERIALS TESTING; PROTHROMBIN; THROMBIN; THROMBOSIS;

EID: 0344085882     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561614     Document Type: Article

References (25)

1. Friedrich, P., Reininger, A. J.: Occlusive thrombus formation on indewelling catheters: in vitro investigation and computational analysis. Thromb. Haemost. 73 (1995) 66-72.
2. Stillman, R. M., Soliman, F., Garcia, L., Sawyer, P. N.: Etiology of catheter-associated sepsis. Correlation with thrombogenicity. Arch. Surg. 112 (1977) 1497-1499.
3. Efsing, H. O., Lindblad, B., Mark, J., Wolff, T.: Thromboembolic complications from central venous catheters: a comparison of three catheter materials. World J. Surg. 7 (1983) 419-423.
4. Lokich, J. J., Bothe, A. Jr., Benotti, P., Moore, C.: Complications and management of implanted venous access catheters. J. Clin. Oncol. 3 (1985) 710-717.
5. Salzman, E. W., Merill, E. W., Kent, K. C.: Interaction of blood with artificial surfaces. In: Colman, R. W., Hirsh, J., Marder, E. W., Salzman, E. W. (eds.): Hemostasis and thrombosis: basic principles and clinical practice. J. B. Lipincott Company, Philadelphia 1994, pp. 1469-1485.
6. International Organization for Standardization, ISO 10993, Part 1,2, 3, 4, 5, 6, 7, 9, 10, 11, 12, (1992-1994).
7. Böswald, M., Girisch, M., Greil, J., Spies, T., Stehr, K., Krall, T., Guggenbichler, J.-P.: Antimicrobial activity and biocompatibility of polyurethane and silicone catheters containing low concentrations of silver: a new perspective in prevention of polymer-associated-foreign-body-infections. Zentralbl. Bakteriol. 283 (1995) 187 200.
8. Böswald, M., Braun, G. G., Lugauer, S., Guggenbichler, J.-P.: Prüfplan zur klinischen Studie: Offen randomisierte, vergleichende Untersuchung zur Erfassung der Wirksamkeit und Verträglichkeit von silberimprägnierten zentralvenösen Verweilkathetern bei Intensivpatienten (1995).
9. Bruhn, H. D., Pelzur, H., Zurburn, K. H.: Thrombin-Marker: Früherkennung der Thrombophilie. Diagnose & Labor 44 (1994) 54-61.
10. Lane, D. A., Bowry, S. K.: The scientific basis for selection of measures of thrombogenicity, Nephrol. Dial. Transplant. 9 (Suppl. 2) (1994) 18-28.
11. Schmidt, B.: Experimental test systems for the assessment of the blood compatibility of materials used in extracorporeal circuits. Neprhol. Dial. Transplant. 9 (Suppl. 2) (1994) 77-82.
12. Tecothane®: Medical grade aromatic thermoplastic polyurethanes, biocompatibility and safety evaluations, Thermedics Inc., 470 Wildwood Street, Woburn, MA 01888, USA (1993).
13. Enzygnost® D-Dimer micro: Enzymimmunoassay zur Bestimmung des humanen Fibrinabbauprodukts D-Dimer. OQBC GC 3 01039 (1039) 1 Januar 1994.
14. Enzygnost® F 1+2 micro: Enzymimmunoassay zur Bestimmung von Human-Prothrombinfragment F 1+2. OWVV G10 EO2 1 November 1994.
15. Enzygnost® TAT micro: Enzymimmunoassay zur Bestimmung von Human-Thrombin/Antithrombin III-Komplex. OWMG G14 EO2 (0459) 1 Januar 1995.
16. Thomas, L.: Labor und Diagnose. 4. Auflage, Die Medizinische Verlagsgesellschaft, Marburg 1992, pp. 579-645, 655-740.
17. Leach, K. R., Kurisu, Y, Carlson, J. E., Repa, I., Epstein, n. H., Urness, M., Sahatjian, R., Hunter, D. W., Casteneda-Zuniga, W, R., Amplatz, K.: Thrombogenicity of hydrophilically coated guide wires and catheters. Radiology 175 (1990) 675-677.
18. Dujardin, R., Pudleiner, H.: Einfluß der chemischen Struktur auf die Biokompatibilität thermoplastischer Polyurethane (Abstract). Xth Colloquium on Biomaterials, Aachen (1997).
19. Seyfert, U. T., Kleinschmidt, S., Stein, S., Wenzel, E.: Thrombogenität von Venenkathetern. Thrombophilie und Antikoagulation, XXXVI. Hamburger Symposium über Blutgerinnung, Hamburg 1993, Ed. Roche Stuttgart, New York, Schattauer, Basel 1994, pp. 217 231.
20. Solomon, D. D., Arnold, W. L., Martin, N. D., Lentz, D. J.: An in vivo method for the evaluation of catheter thrombogenicity. J. Biomed. Mater. Res. 21 (1987) 43-57.
21. Schwarzmann, G., Sefrin, P.: Thrombogenicity of central venous catheters: comparison of two polyurethane catheters. Infusionsther. Transfusionsmed. 20 (1993) 148-156.
22. Amplatz, K.: A new, simple test for thrombogenicity. Radiology 120 (1976) 53-55.
23. Kallmes, D. F., McGraw, J. K., Evans, A. J., Mathis, J. M., Hergenrother, R. W., Jensen, M. E., Cloft, H. J., Lopes, M., Dion, J. E.: Thrombogenicity of hydrophilic and nonhydrophilie microcathelers and guiding catheters. Am. J. Neuroradiol. 18 (1997) 1243-1251.
24. Bambauer, R., Mestres, P., Pirrung, K. J., Sioshansi, P.: Scanning electron microscopic investigation of catheters for blood access. Artif. Organs 18 (1994) 272-275.
25. Lindhout, T.: Biocompatibility of extracorporeal blood treatment. Selection of haemostatic parameters. Nephrol. Dial, Transplant. 9 (Suppl. 2) (1994) 83-89.